Figure 5.
Kaplan-Meier product estimates of progression-free survival of patients given G-PBMCs (n = 71) or marrow grafts (n = 18).

Kaplan-Meier product estimates of progression-free survival of patients given G-PBMCs (n = 71) or marrow grafts (n = 18).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal